Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The objective is to compare the pharmacokinetics and pharmacodynamics of IPX054 and
carbidopa-levodopa immediate-release tablets in subjects with idiopathic Parkinson's disease
who are currently being treated with a stable regimen of carbidopa-levodopa immediate-release
tablets.